Bausch + Lomb (BLCO -6.42%), a global eye health company known for its contact lenses, surgical devices, and eye pharmaceuticals, released results for the second quarter of fiscal 2025 on July 30, 2025. The main headline from the release is GAAP revenue growth of 5% year over year to $1.278 billion, beating analyst expectations by$18 million. Adjusted earnings per share (EPS) (non-GAAP) reached $0.07, beating the consensus estimate by$0.01 but falling short of last year's figure of $0.13. Top line growth ...